Maridebart Cafraglutide
NCT05669599
Amgen · Phase 2 · Completed · Enrollment 592
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Maridebart Cafraglutide
Amgen · Phase 2 · Completed · Enrollment 592
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.